1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics in North America Countries, November 2019

Healthcare Analysis & Statistics in North America Countries, November 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

1-30 of about 14000 reports

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

  • $ 19500
  • Industry report
  • September 2019

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and InstrumentationThe ...

  • Industries : Pathology
  • Countries : Europe, United States, Japan, World
Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 19500
  • Industry report
  • September 2019

Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewSummaryThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : United States, World, Japan, Europe
Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 19500
  • Industry report
  • August 2019

Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ...

  • Industries : Pathology
  • Countries : Japan, World, United States, Europe
Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

  • $ 18500
  • Industry report
  • November 2019

Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ...

  • Industries : Diagnostics
  • Countries : United States, Europe, Japan
Global Automated Microbiology Market for over 100 Tests

Global Automated Microbiology Market for over 100 Tests

  • $ 18500
  • Industry report
  • September 2019

Global Automated Microbiology Market for over 100 Tests: US, Europe, JapanLeadingMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities emerging ...

  • Industries : Pathology
  • Countries : World, United States, Japan
Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 18500
  • Industry report
  • September 2019

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis new report ...

  • Industries : Pathology
  • Countries : Japan, World, United States, Europe
Global Blood Typing, Grouping and Infectious Disease NAT Screening Market in the US, Europe, Japan: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

Global Blood Typing, Grouping and Infectious Disease NAT Screening Market in the US, Europe, Japan: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

  • $ 17500
  • Industry report
  • August 2019

Global Blood Typing, Grouping and Infectious Disease NAT Screening Market in the US, Europe, Japan: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and ...

  • Industries : Pathology
  • Countries : United States, Europe, Japan, World
Global Cancer Diagnostics Market Analysis: Emerging Opportunities in the USA, Europe, Japan--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation

Global Cancer Diagnostics Market Analysis: Emerging Opportunities in the USA, Europe, Japan--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation

  • $ 17500
  • Industry report
  • August 2019

Global Cancer Diagnostics Market Analysis: Emerging Opportunities in the USA, Europe, Japan--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and In ...

  • Industries : Medical Biotechnology
  • Countries : World, United States, Japan, Europe
Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • $ 14500
  • Industry report
  • October 2019

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

  • $ 14500
  • Industry report
  • October 2019

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 14500
  • Industry report
  • August 2019

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewSummaryThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : United States, Japan, Europe, World
Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

  • $ 12500
  • Industry report
  • November 2019

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation ...

  • Industries : Diagnostics
  • Countries : World, United States, Europe, Japan
Female Infertility: Opportunity Analysis and Forecasts to 2028

Female Infertility: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Female Infertility: Opportunity Analysis and Forecasts to 2028SummaryThe report “Female Infertility: Opportunity Analysis and Forecasts to 2028” expects the Female Infertility (FI) drug market to grow ...

  • Industries : Therapy, Pathology, Healthcare, Pharmaceutical
  • Countries : United States
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028SummaryThe latest report “Ovarian Cancer: Opportunity Analysis and Forecasts to 2028” values the Ovarian Cancer market at $1.8bn in 2018 across ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World, Japan
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028SummaryHemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively.Patients ...

  • Industries : Pathology, Healthcare
  • Countries : United States, World, China, East Asia, North America, Japan
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028SummaryThe prostate cancer market will undergo a moderate increase at a compound annual growth rate (CAGR) of 3.3% from an estimated $9.3bn ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States, East Asia, Japan, China, World, North America
Alopecia Areata: Opportunity Analysis and Forecasts to 2028

Alopecia Areata: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • August 2019

Alopecia Areata: Opportunity Analysis and Forecasts to 2028SummaryAlopecia areata (AA) is the second most common non-scarring alopecia and there are no clear reasons for the onset of the condition; however, ...

  • Industries : Pathology, Therapy
  • Countries : United States
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • August 2019

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028SummaryAllergic rhinitis (AR) is a common, IgE-mediated inflammatory disease in which an individual reacts to an otherwise innocuous ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical, Chronic Disease, Pathology
  • Countries : United States, Japan, World, East Asia, North America
Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Tecentriq

Tecentriq

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTecentriq (atezolizumab; Roche/Chugai) is a fully humanized monoclonal antibody that targets programmed death-ligand 1 (PD-L1). PD-L1 is expressed on the surface of antigen-presenting cells ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
tislelizumab

tislelizumab

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTislelizumab (BeiGene) is a humanized monoclonal antibody that was designed to bind to the PD-1 receptor and prevent binding of PD-L1. In addition, tislelizumab was designed to minimize binding ...

  • Industries : Pathology, Medical Biotechnology
  • Countries : United States
Lenvima

Lenvima

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewLenvima (lenvatinib; Eisai/Merck and Co) is an orally available small molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Keytruda

Keytruda

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewKeytruda (pembrolizumab; Merck and Co) is a humanized monoclonal antibody designed to inhibit the PD-1 co-inhibitory receptor. The interaction between PD-1 and its primary ligand, PD-L1, inhibits ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Stivarga

Stivarga

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewStivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Cabometyx

Cabometyx

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor which has been shown to suppress tumor growth and metastasis by inhibiting the activity of multiple ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Imfinzi

Imfinzi

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewImfinzi (durvalumab; AstraZeneca) is a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The interaction between PD-L1 and its receptor, programmed death-1 (PD-1), ...

  • Industries : Pathology, Cancer
  • Countries : European Union, Japan, United States
Menveo

Menveo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenveo (quadrivalent oligosaccharide diphtheria CRM-197 conjugate vaccine; GlaxoSmithKline) is a quadrivalent meningococcal glycoconjugate vaccine that uses CRM-197, a natural mutant of the ...

  • Industries : Therapy, Pathology
  • Countries : United States, European Union
Menactra

Menactra

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewMenactra (Sanofi) is a quadrivalent polysaccharide diphtheria toxoid conjugate vaccine indicated for active immunization to prevent invasive meningococcal disease (IMD) caused by Neisseria ...

  • Industries : Therapy, Pathology
  • Countries : United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on